Ascletis (partner of WuXi STA) receives approval from National Drug Administration of China (CNDA, former CFDA) of its C...
Hebron Technology Co., Ltd., a developer, manufacturer and installer of valves and pipe fittings for use in the pharmace...
Shanghai Kinetic Medical Co recently announced that it plans to take over US medical technology company Elliquence LLC f...
Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specialized in the application of d...
Zai Lab, a Shanghai-based innovative biopharmaceutical company, recently announced that Mr William Liang has b...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
GE Healthcare will provide China-based Xiangxue Pharmaceutical (XPH) with a FlexFactory for cell therapy. The system, ex...
Oncologie, an innovative biopharmaceutical company, recently announced that it is launching operations in both Boston an...
A group of researchers from Chinese Academy of Sciences and Peking University Third Hospital has developed a new type of...
China has approved the first domestically developed, long-acting injectable HIV drug Albuvirtide, which could be a boon ...
Singapore- Wize Pharma, a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorder...
Ally Bridge Group (ABG), a China-centered healthcare investor, has completed a Series A investment, as the first part of...
P-MEC China will be held at the Shanghai New International Expo Center (SNIEC), Shanghai, China, from 20-22 Ju...
Singapore- Blueprint Medicines and CStone Pharmaceuticals, a privately-held biopharmaceutical company announce an e...
Xynomic Pharma, a clinical stage US-China oncology drug development company, recently announced that it has complete...
SenseTime Group has raised $620 million at a valuation of more than $4.5 billion just months after scoring a similar amo...
Gilead Sciences, Inc. has announced that the China Drug Administration (CDA) has approved Epclusa for the treatment of a...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
